Quantcast
Last updated on April 18, 2014 at 14:31 EDT

Latest Medical genetics Stories

2013-11-06 23:22:35

2014 Muscle Team Gala expected to raise more than $1 million. NEW YORK, (PRWEB) November 06, 2013 Metro New York's top pro athletes will join together to put their muscle behind finding treatments and cures for muscle disease at a special kickoff event for the 17th annual New York Muscle Team® Gala on Tuesday, Nov. 19, at 6 p.m. to benefit the Muscular Dystrophy Association. The kickoff event will take place at The Lighthouse at Chelsea Piers, Pier 61 (Hudson River and 23rd...

Genetic Testing Technique Will Accelerate Personalized Medicine
2013-11-04 03:57:33

redOrbit Staff & Wire Reports - Your Universe Online In a development expected to improve the process of matching organ donors and understanding how genes contribute to diseases, researchers have devised a method that can help determine whether or not a specific genetic sequence came from an individual’s mother or father. The technique, which was developed by experts from the Ludwig Institute for Cancer Research and is described in the latest edition of the journal Nature...

2013-10-30 15:35:50

Scientists in The Research Institute at Nationwide Children's Hospital have found a way to overcome one of the biggest obstacles to using viruses to deliver therapeutic genes: how to keep the immune system from neutralizing the virus before it can deliver its genetic payload. In a study published recently in Molecular Therapy, researchers found that giving subjects a treatment to temporarily rid the body of antibodies provides the virus safe passage to targeted cells, allowing it to release a...

11 New Alzheimers Genes Found
2013-10-28 11:57:17

Brett Smith for redOrbit.com - Your Universe Online In the biggest international study ever conducted on Alzheimer's disease, the International Genomics Alzheimer's Project (I-GAP) consortium has found eleven new regions of the genome involved in the onset of the neurodegenerative disorder. The project involved searching the DNA of over 74,000 volunteers for new genetic risk factors linked to late-onset Alzheimer's disease, the most frequently seen form of the disease. I-GAP, made up of...

2013-10-24 08:36:30

Newly Insured to Receive Access to Preventive Genetics Services ST. PETERSBURG, Fla., Oct. 24, 2013 /PRNewswire/ -- The most important way to join the fight against breast cancer is to educate women about their individual risk, and the options for those at high risk. "The majority of women do not have a BRCA gene mutation, but other factors may place some at high risk for breast cancer," said Amber Trivedi, M.S., C.G.C., who leads genetics educational initiatives at InformedDNA....

2013-10-23 23:02:23

Seminar is open to the public on Saturday, Nov. 2 at Rapides Regional Medical Center in Alexandria, LA from 10 a.m. – 2 p.m. Shreveport, LA (PRWEB) October 23, 2013 The Muscular Dystrophy Association invites residents in the Ark-La-Tex area to fight back against muscle disease by participating in the "Living with a Muscle Disease" seminar on Saturday, Nov. 2 at Rapides Regional Medical Center in Alexandria, La. from 10 a.m. – 2 p.m. "Living with a Muscle Disease"...

2013-10-23 08:30:14

CAMBRIDGE, Mass., Oct. 23, 2013 /PRNewswire/ -- NextCODE Health, a new private company enabling accelerated diagnosis of genetic diseases through the use of sequence data, announced today that it has secured an exclusive license for sequence-based clinical diagnostic applications using technology developed by deCODE genetics. The company also secured $15 million in Series A financing from Polaris Partners and ARCH Venture Partners, which will allow NextCODE to rapidly scale the integration...

2013-10-23 08:29:43

HAYWARD, Calif. and WUHAN, China, Oct. 23, 2013 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD) and Kindstar Global (Kindstar) today announced that Kindstar will begin validating and implementing ACD's RNAscope® technology-based molecular diagnostic assays in its clinical laboratories. The initial suite of tests to be launched include RNAscope HPV, a high-risk HPV test to determine HPV status in cervical pre-cancer and head & neck cancer, and CTCscope, a blood-based test to...

2013-10-22 08:33:03

Fully Integrated Gene Therapy Company with Deep Clinical Pipeline Spun out of The Children's Hospital of Philadelphia PHILADELPHIA, Oct. 22, 2013 /PRNewswire/ -- Spark Therapeutics, a new, fully integrated company developing gene-based medicines for a wide range of debilitating diseases, announced today it has launched with a $50 million capital commitment from The Children's Hospital of Philadelphia (CHOP) to advance and commercialize multiple ongoing programs with clinical proof of...

2013-10-16 11:53:21

Vitelliform macular dystrophy, also known as Best disease, is one of a group of vision-robbing conditions called bestrophinopathies that affect children and young adults. Caused by inherited mutations in the BEST1 gene, these diseases cause severe declines in central vision as patients age. With a new study, University of Pennsylvania researchers report "encouraging" findings that mark the first clear step in developing a gene therapy that could prevent vision loss or event restore vision...